GlobeNewswire

Trogenix appoints industry veterans John Young as Chair and Josh Murray as Non-Executive Director to support global strategy, commercial foundation and patient access
10/11/2026
John brings more than 35 years of operational and commercial leadership with extensive experience in bringing medicines to market at global scale Josh brings deep capital markets and strategic experience to support the [...]
Roche presents new data across pharmaceuticals and diagnostics from its growing Alzheimer’s disease portfolio at CTAD 2026
10/11/2026
Updated Phase Ib/IIa Brainshuttle™ AD study data for trontinemab demonstrating rapid amyloid removal dynamics and changes in key biomarkers Phase III PrevenTRON study design specifics for trontinemab in preclinical [...]
Valneva Reports Sustained 94% Seroresponse Five Years After a Single Dose of Chikungunya Vaccine IXCHIQ®
10/11/2026
94% of participants maintained seroresponse five years after a single vaccination Comparable antibody persistence observed in older (65+) and younger adults Data further reinforce IXCHIQ ® 's differentiated profile with [...]
Valneva annonce un taux de séroréponse de 94% cinq ans après une dose unique du vaccin contre le chikungunya IXCHIQ®
10/11/2026
94% des participants ont maintenu une séroréponse cinq ans après une dose unique du vaccin La persistance des anticorps chez les adultes âgés de 65 ans et plus est comparable à celle des jeunes adultes Ces données [...]
Australian therapy aimed at halting MND progression and restoring function advances to national Phase 2 trial
10/11/2026
Video interviews, overlay and photos here BRISBANE, Australia, Nov. 10, 2026 (GLOBE NEWSWIRE) -- An Australian-developed therapy aimed at halting the progression of motor neurone disease (MND) and restoring function by [...]
Harrow Announces Third Quarter 2026 Financial Results
09/11/2026
Third Quarter 2026 and Selected Highlights: Record third quarter revenue of $99.3 million, up 41% sequentially and 39% year over year Branded revenue of $83.5 million, up 62% year over year and approximately 84% of [...]
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2026
09/11/2026
Awarded $15 Million Procurement Contract from Canadian Department of National Defence for Oral TPOXX in October Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- SIGA [...]
Xenon Reports Q3 2026 Financial Results and Provides Business Update
09/11/2026
New Drug Application for azetukalner in focal seizures submitted to U.S. Food & Drug Administration in September 2026 Expanding potential opportunity in epilepsy through ongoing Phase 3 X-TOLE3 and X-ACKT studies [...]
POLYRIZON ADOPTS LIMITED DURATION SHAREHOLDER RIGHTS PLAN
09/11/2026
TEL AVIV, Israel, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, [...]
MBX Biosciences Reports Third Quarter 2026 Financial Results and Corporate Highlights
09/11/2026
Enrollment in pivotal Phase 3 oPTimize trial of once-weekly canvuparatide underway 12-week MAD (Part C, Cohort 1) data for MBX 4291, a GLP-1/GIP co-agonist prodrug for obesity designed for once-monthly dosing, on track [...]
SIGA Announces Retirement of Chief Scientific Officer Dennis Hruby, Ph.D.
09/11/2026
Concludes 30-Year Tenure Leading Development of TPOXX®, the First FDA-Approved Antiviral for the Treatment of Smallpox NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies (NASDAQ: SIGA), a commercial stage [...]
IRulya Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
09/11/2026
NEW HAVEN, Conn., Nov. 09, 2026 (GLOBE NEWSWIRE) -- IRulya Therapeutics Inc. (Nasdaq: IRLA), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious [...]
Nanox Announces That Board Has Approved Cost Reduction and Operational Efficiency Measures
09/11/2026
The Board approved plan target s a 25%–30% reduction in annualized operating expenses, compared to annualized 2026 GAAP and non-GAAP operating expenses, once fully implemented, expected by the end of Q 1 202 7 Cost [...]
Five Vital Nutrients Bestsellers Earn TESTED by SuppCo Certification Verifying Label Claims
09/11/2026
MIDDLETOWN, Conn., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Vital Nutrients , a practitioner-founded nutritional supplement company, today announced that five of its dietary supplements have earned TESTED by SuppCo [...]
Syndax Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
09/11/2026
NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that in connection with the hiring, [...]
Robert Whitfield MD PLLC Marks Two Years of the SHARP Method, Drawing Surgical Patients From 40 States and Abroad
09/11/2026
First published by board-certified plastic surgeon Dr. Robert Whitfield in his book two years ago, the program pairs individualized health assessment before surgery with patient education and in-clinic recovery support [...]
Digbi Health Reports 18.4% Weight Loss With Tirzepatide, Challenges One-Size-Fits-All GLP-1 Care
09/11/2026
Real-world results from 3,181 members across 10 employers, to be presented at Obesity Week® 2026, beat every published cohort on the same drug with standard care. The difference: precision biology and AI that [...]
Mesa Labs Announces Second Quarter Fiscal Year 2027 Results and Issues First Full-Year Guidance
09/11/2026
LAKEWOOD, Colo., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of critical quality control solutions and life sciences [...]
Cellectis to Report Third Quarter Financial Results on November 12, 2026
09/11/2026
NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a genome engineering company developing genetic medicines for diseases that today demand a lifetime of [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum